ADHD (Methylphenidate, Dexamfetamine, Atomoxetine and Lisdexamphetamine) shared care guideline
(Methylphenidate, Dexamfetamine, Atomoxetine and Lisdexamphetamine)
Shared care guideline for the treatment of Attention Deficit Hyperactivity Disorder in children, young people and adults
Date: 22 October 2015 to 31 December 2098
- TypeShared Care Guidelines
- Clinical Support Group
Paediatrics
Brain and mental health
- Part of
- Drug
- Traffic lightAmber (SCG)
- Conditions and indicators
- Clinical support by body system
- Due for review01 February 2021
- Link
- Bypass detail page
- Bypass detail page and
Do you want to add this to your CPD record?
Did you find this page helpful?